TESTOSTERONE ENANTHATE

Search structure
Trade Names:
Synonyms:
Status: Approved (1953)
Entry Type: Small molecule
Molecule Category: UNKNOWN Prodrug
UNII: 7Z6522T8N9
Parent Compound: TESTOSTERONE

Structure
InChI Key VOCBWIIFXDYGNZ-IXKNJLPQSA-N
Smile CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C26H40O3
Molecular Weight 400.6
AlogP 6.4
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 6.0
Polar Surface Area 43.37
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Androgen Receptor agonist Wikipedia FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hypogonadism 4 D007006 ClinicalTrials
Weight Loss 2 D015431 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 2 D029424 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
HIV Wasting Syndrome 2 D019247 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Muscular Dystrophy, Facioscapulohumeral 1 D020391 ClinicalTrials

Related Entries

Scaffolds

Parent
Mixture

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Vascular disorders
40.0
Cardiac disorders
16.29
Nervous system disorders
8.04
Psychiatric disorders
7.56
General disorders and administration site conditions
7.52
Respiratory, thoracic and mediastinal disorders
6.96
Investigations
4.84

Cross References

Resources Reference
CAS NUMBER 315-37-7
ChEBI 9464
ChEMBL CHEMBL1200335
DrugBank DB13944
DrugCentral 4609
FDA SRS 7Z6522T8N9
Human Metabolome Database HMDB0005814
KEGG C08157
PubChem 9416
SureChEMBL SCHEMBL42687
ZINC ZINC000003876080
CONTENTS